Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000505913 | SCV000603220 | likely benign | not provided | 2017-05-02 | criteria provided, single submitter | clinical testing | The c.1770G>A variant (rs61731905) has not been previously associated with any mitochondrial. This variant is rare in the general population, and is listed in the Genome Aggregation Database (gnomAD) browser with an overall frequency of 0.003% (identified in71 out of 246,118 chromosomes). However, this variant affects a weakly conserved nucleotide (Alamut software v 2.8.1), does not alter the amino acid sequence of CPT1A protein, and is not predicted to alter CPT1A mRNA splicing (Alamut software v 2.8.1). Therefore, the c.1770G>A variant is likely to be benign. |
Labcorp Genetics |
RCV000693494 | SCV000821365 | likely benign | Carnitine palmitoyl transferase 1A deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003403187 | SCV004122859 | likely benign | not specified | 2023-10-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003962409 | SCV004784666 | likely benign | CPT1A-related disorder | 2020-06-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |